Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?

• Albert Picado ,

  * E-mail: albert.picado@finddx.org

  Affiliation Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland

  http://orcid.org/0000-0001-7344-628X

  ⨯
• Andrea Angheben,

  Affiliation Centre for Tropical Diseases, Hospital Sacro Cuore, Don Calabria, Negrar, Verona, Italy

  ⨯
• Andrea Marchiol,

  Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

  ⨯
• Belkisyolé Alarcón de Noya,

  Affiliation Immunology Section, Instituto de Medicina Tropical, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela

  ⨯
• Laurence Flevaud,

  Affiliation Médecins Sans Frontières Operational Centre Barcelona-Athens (MSF OCBA), Barcelona, Spain

  ⨯
• Maria Jesus Pinazo,

  Affiliation ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain

  ⨯
• Montserrat Gállego,

  Affiliations ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain, Secció de Parasitologia, Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain

  ⨯
• Sheba Meymandi,

  Affiliation Department of Cardiology, Center of Excellence for Chagas Disease at Olive View-UCLA Medical Center, Sylmar, California, United States of America

  ⨯
• Silvia Moriana

  Affiliation The Global Chagas Disease Coalition, Barcelona, Spain

  ⨯